Screening, assessment and referral to appropriate health professionals is required to meet the identified needs of the woman, her carer and family. In addition to the common issues identified in the Appendix, specific issues that may arise at this time include: emotional and psychological distress from anticipatory grief, fear of death/dying, anxiety/ depression, interpersonal problems…

The lead clinician should: discuss the treatment plan with the woman and carer, including the intent of treatment and expected outcomes, and provide a written plan provide the woman and carer with information on the possible side effects of treatment, self-management strategies and emergency contacts initiate a discussion regarding advance care planning with the woman…

The lead clinician should: be open to and encourage discussion about the expected disease course, with due consideration to personal and cultural beliefs and expectations discuss palliative care options including inpatient and community-based services as well as dying at home and subsequent arrangements provide the woman and her carer with the contact details of a…

The lead clinician should discuss end-of-life care planning and transition planning to ensure the woman’s needs and goals are addressed in the appropriate environment. The woman’s general practitioner should be kept fully informed and involved in major developments in the woman’s illness trajectory.

Screening, assessment and referral to appropriate health professionals is required to meet the identified needs of an individual, their carer and family. In addition to the common issues outlined in the Appendix, specific issues that may arise include: emotional and psychological distress resulting from fear of death/dying, existential concerns, anticipatory grief, communicating wishes to loved…

The National Cervical Screening Program aims to prevent cervical cancer by detecting early changes in the cervix. A five-yearly HPV test for women aged 25–74 years began on 1 December 2017 to replace the previous two-yearly Pap test for women aged 18–69 years. The cervical screening test checks for the presence of HPV, the causal…

Timeframes for completing investigations should be informed by evidence-based guidelines (where they exist) while recognising that shorter timelines for appropriate consultations and treatment can reduce the woman’s distress. The following recommended timeframes are based on expert advice from the Cervical Cancer Working Group: For obvious abnormalities, a colposcopy within two weeks of referral. Diagnostic investigations…

The number of new cases of cervical cancer is likely to be dramatically reduced as the benefits of human papillomavirus (HPV) vaccination are realised (Hall et al. 2018). It is likely that in the future, cervical cancer will largely (but not exclusively) be confined to women who have not been immunised, or for whom immunisation…

An individualised clinical assessment is required to meet the identified needs of the woman, her carer and family; referral should be as required. In addition to common issues identified in the Appendix, specific needs that may arise at this time include: treatment for physical symptoms such as pain and fatigue help with the emotional distress…

Timeframes should be informed by evidence-based guidelines (where they exist) while recognising that shorter timelines for appropriate consultations and treatment can reduce the woman’s distress. The following recommended timeframes are based on expert advice from the Cervical Cancer Working Group(1): Cervical testing results should be available and the woman reviewed by her general practitioner within…